sEphB4-HAS
N/A
Report date: 2023/01/01 08:30:45
Base Information
Drug NamesEphB4-HAS
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVasgene Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesVasgene Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A